Europe

MS Does Not End at the Clinic Door. It Follows People Into Work, Money and Relationships.

Germany Is Paying the Price for Leaving Tardive Dyskinesia Behind

Europe’s next stroke bet: can Factor XIa inhibition change prevention without raising bleeding risk?

MASH, a serious fatty liver disease, is becoming a cardiometabolic condition

ESC Cardio-Oncology 2026: Cancer therapy is getting smarter. Cardiac protection is still playing catch-up.

Cardio-oncology demand is rising, but training gaps are holding systems back

Ebola Modelling Shows the Outbreak May Be Bigger Than the Count

Personalised cardiology cannot succeed if women’s hearts still follow men’s pathways

Chronic pain may be a cardiovascular warning sign, not just a symptom
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
